Cargando…

CETP inhibition in the REVEAL trial: could we aim higher?

Detalles Bibliográficos
Autores principales:	Sahebkar, Amirhossein, Mikhailidis, Dimitri P., Banach, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444706/ https://www.ncbi.nlm.nih.gov/pubmed/32864013 http://dx.doi.org/10.5114/aoms.2020.97968

Ejemplares similares

Response letter: Management of statin‐induced myopathies: Much demands and still (almost) empty hands!
por: Sahebkar, Amirhossein, et al.
Publicado: (2017)

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
por: Anagnostis, Panagiotis, et al.
Publicado: (2023)

The Link Between Human and Transgenic Animal Studies Involving Postprandial Hypertriglyceridemia and CETP Gene Polymorphisms
por: Kolovou, Genovefa D, et al.
Publicado: (2009)

Drucebo effect – the challenge we should all definitely face!
por: Banach, Maciej, et al.
Publicado: (2021)

Cholesterol in Relation to COVID-19: Should We Care about It?
por: Radenkovic, Dina, et al.
Publicado: (2020)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Impact of bariatric surgery on circulating PCSK9 levels as a marker of cardiovascular disease risk: a meta-analysis
por: Jamialahmadi, Tannaz, et al.
Publicado: (2022)

Sex-associated effect of CETP and LPL polymorphisms on postprandial lipids in familial hypercholesterolaemia
por: Anagnostopoulou, Katherine K, et al.
Publicado: (2009)

Are we getting to lipid targets in real life?
por: Katsiki, Niki, et al.
Publicado: (2010)

Perivascular adipose tissue in cardiovascular diseases
por: Katsiki, Niki, et al.
Publicado: (2020)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
por: Penson, Peter E., et al.
Publicado: (2018)

Doctors Could Face Significant Legal Liability if We Reallocate Ventilators
por: Mareiniss, Darren P.
Publicado: (2021)

Statins and C-reactive protein: in silico evidence on direct interaction
por: Shakour, Neda, et al.
Publicado: (2020)

The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency
por: Radbakhsh, Shabnam, et al.
Publicado: (2023)

Obstructive sleep apnea and cardiovascular disease: Is mean platelet volume one of the links?
por: Papanas, Nikolaos, et al.
Publicado: (2016)

Could We Prevent Displacing the Undisplaced Fracture Neck of Femur? To the Editor
por: Dhamangaonkar, Anoop C.
Publicado: (2012)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020)

18F-Fluorodeoxyglucose Uptake in Abdominal Aortic Aneurysms: A Useful Biomarker of AAA Rupture Risk
por: Paraskevas, Kosmas I., et al.
Publicado: (2014)

Lipid profile and glucose changes after supplementation with astaxanthin: a systematic review and meta-analysis of randomized controlled trials
por: Ursoniu, Sorin, et al.
Publicado: (2015)

Antibody-drug conjugates: smart weapons against cancer
por: Hayat, Seyed Mohammad Gheibi, et al.
Publicado: (2019)

Exosomes as nanocarriers for siRNA delivery: paradigms and challenges
por: Shahabipour, Fahimeh, et al.
Publicado: (2016)

Nutrition, Nutraceuticals and Bioactive Compounds in the Prevention and Fight against Inflammation
por: Surma, Stanisław, et al.
Publicado: (2023)

Cholesteryl Ester Transfer Protein (CETP) Deficiency and CETP Inhibitors
por: Mabuchi, Hiroshi, et al.
Publicado: (2014)

Obstructive sleep apnoea syndrome and cardiovascular risk
por: Kostapanos, Michael S., et al.
Publicado: (2012)

Suicide in Ghana: How Could the Community-Based Health Planning and Service (CHPS) Effectively Contribute to Its Prevention?
por: ASSAN, Abraham, et al.
Publicado: (2019)

CETP Inhibition: Past Failures and Future Hopes
por: Kosmas, Constantine E., et al.
Publicado: (2016)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

Disability and Happiness in Iran: What Can We Do?
por: SOLTANI, Shahin, et al.
Publicado: (2018)

Effects of Quercetin on Blood Pressure: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Serban, Maria‐Corina, et al.
Publicado: (2016)

A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations
por: Serban, Corina, et al.
Publicado: (2015)

How can we weather a virus storm? Health prediction inspired by meteorology could be the answer
por: Buizza, Roberto, et al.
Publicado: (2021)

J-AIM: A welcome step
por: Deodhar, N. S.
Publicado: (2010)

J-AIM fulfills important need
por: Joshi, V. R.
Publicado: (2010)

Curcumin: An effective adjunct in patients with statin‐associated muscle symptoms?
por: Sahebkar, Amirhossein, et al.
Publicado: (2016)

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial
por: Menon, Venu, et al.
Publicado: (2020)

The mechanisms of atrial fibrillation in hyperthyroidism
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_l8emno4kdpgmia825l43h06c72